Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06969235 · ClinicalTrials.gov registry record · NA
Examining the Role of Executive Functioning in Family-Based Intensive Health Behavior and Lifestyle Treatment
A NA study of Pediatric Overweight, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06969235: Recruiting NA study of Pediatric Overweight, sponsored by University of Missouri-Columbia.
NCT06969235 is a NA study of Pediatric Overweight that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06969235, a NA study of Pediatric Overweight, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this open trial feasibility study are to examine the impacts of intensive health behavior and lifestyle treatment (IHBLT) on youth and caregiver executive functioning (EF), weight status, health behaviors (dietary intake, disordered eating, physical activity), and psychological functioning. Investigators propose to enroll 10 youth 13 to 17 years of age who have overweight or obesity (OV/OB) and a primary caregiver. Families will receive six months of evidence-based family focused group IHBLT based on social, cognitive, and family systems theories. Families will complete assessments of EF skills (objective and self-report), weight status, dietary intake, physical activity, and psychological functioning at pre- and post-treatment.
Primary Outcome
Youth T-score on the Continuous Performance Test Third Edition (CPT-3) Commissions subscale; T-scores (M = 50, SD = 10) used with higher scores representing worse executive functioning (EF)
Conditions Studied
Interventions
- BEHAVIORAL intensive health behavior and lifestyle treatment
Study Locations (1)
Missouri
- College of Health Sciences, University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-05-05 |
| Est. Completion | 2027-08 |
| Phase | NA |
What NCT06969235 shows while recruiting
NCT06969235 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Pediatric Overweight appearing as the primary indexed condition, and to 1 intervention - of which intensive health behavior and lifestyle treatment is the first listed.
NCT06969235 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06969235 about?
NCT06969235 is a clinical study titled "Examining the Role of Executive Functioning in Family-Based Intensive Health Behavior and Lifestyle Treatment". The objectives of this open trial feasibility study are to examine the impacts of intensive health behavior and lifestyle treatment (IHBLT) on youth and caregiver executive functioning (EF), weight status, health behaviors (dietary intake, disordered eating, physical activity), and psychological fun...
What is the current status of trial NCT06969235?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-05-05. Estimated completion is 2027-08.
What conditions does trial NCT06969235 study?
This clinical trial studies the following conditions: Pediatric Overweight.
What interventions are being tested in trial NCT06969235?
The interventions under investigation include: intensive health behavior and lifestyle treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06969235?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06969235 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06969235's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI